•
Germany-based Siemens Healthineers AG (ETR: SHL) released its results for the first quarter of fiscal year 2025, ended December 31, 2024. The company showcased an excellent equipment book-to-bill ratio of 1.21 and comparable revenue growth of 5.7%. This marks a strong start to the fiscal year, driven by growth across…
•
Siemens (Shenzhen) Magnetic Resonance Co., Ltd., a wholly-owned subsidiary of Siemens Ltd., China, has officially laid the foundation for its new high-end medical equipment R&D and manufacturing base project in Nanshan District, Shenzhen. This significant investment marks a major expansion of Siemens’ capabilities in the region. Project Details and TimelineThe…
•
Germany-based Siemens Healthineers AG (ETR: SHL) has announced the completion of its acquisition of Advanced Accelerator Applications (AAA) Molecular Imaging from Novartis (NYSE: NVS). This strategic move is anticipated to significantly enhance Siemens’ PETNET Solutions sector, strengthening its position in the field of positron emission tomography (PET) and radiopharmaceuticals. Enhancing…
•
Germany-based medical device giant Siemens Healthineers AG (ETR: SHL) has released its financial results for the fourth quarter of fiscal 2024, ended September 30, 2024, and the full fiscal year 2024. The company achieved its targets for revenue growth and earnings per share for FY2024, demonstrating resilience amidst challenging market…
•
Germany’s medical technology leader Siemens Healthineers AG (ETR: SHL) has reported its financial results for the second quarter of fiscal 2024, which concluded on March 31, 2024. The company achieved total revenues of EUR 5.44 billion (USD 5.85 billion), marking a growth of 3% year-on-year (YOY) at constant currency. Siemens…
•
Germany’s Siemens Healthineers AG (ETR: SHL) has entered into an eight-year value partnership with Xi’an Daixing Hospital, a top-tier Class 3A medical institution located in Northwestern China. The collaboration aims to delve into various areas, including the construction of an innovative ecosystem, talent development, international exchange initiatives, scientific research consultation,…
•
Siemens Healthineers AG (ETR: SHL), a leading medical technology company based in Germany, has entered into a strategic partnership with the Haidian district government in Beijing. The collaboration aims to foster international medical talent cultivation, develop a medical technology innovation ecosystem, and enhance medical industry translation cooperation, among other initiatives.…
•
Siemens Healthineers AG (ETR: SHL), based in Germany, has released its quarterly report for the first quarter of the fiscal year 2024, concluded on December 31, 2023. On a currency-adjusted basis, sales increased by 5.7% to EUR 5.18 billion (USD 5.6 billion). When excluding the impact of COVID-19-related sales, the…
•
Siemens Healthineers AG (ETR: SHL), a leading life sciences company based in Germany, has entered into a strategic partnership with the College of Radiology at Shandong First Medical University. The collaboration aims to encompass several key initiatives: The duo will jointly construct China’s inaugural “Medical Imaging Metaverse Immersive Teaching and…
•
China’s Sun Yat-sen Memorial Hospital, affiliated with Sun Yat-sen University, has entered into a strategic partnership with Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) at the 6th China International Import Expo (CIIE) in Shanghai. The collaboration focuses on the science research, application, and translation of metaverse visualization surgery,…
•
Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) has released its financial results for the third quarter of its 2023 fiscal year, which ended on June 30. The company reported global revenues of EUR 5.2 billion (USD 5.6 billion), marking a 3.6% year-on-year (YOY) growth in constant exchange rate…
•
German healthcare giant Siemens Healthineers (ETR: SHL) has partnered with the China Chest Pain Center to launch the “Rising Star smart chest pain center standardized construction training program.” This initiative is designed to enhance the standardized construction of chest pain treatment processes and improve clinical intervention diagnosis and treatment capabilities.…
•
Siemens Healthineers AG (ETR: SHL) released its financial results for the fiscal year Q3 2022 period ending June 30. The company reported global revenues of EUR5,186 million (USD5,279 million) over the three months, marking a 5.7% year-on-year (YOY) decline in constant currency terms. This decline was primarily attributed to a…